TY - PAT
T1 - Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)
AU - Fondazione Istituto Italiano di Tecnologia
AU - The regents of the University of California
AU - BOTTEGONI, Giovanni
AU - DE SIMONE, Alessio
AU - RUDA, Gian Filippo
AU - CAVALLI, Andrea
AU - BANDIERA, Tiziano
AU - PIOMELLI, Daniele
PY - 2015
Y1 - 2015
N2 - The invention provides compounds of Formula (I) or pharmaceutically acceptable salts thereof wherein Ar', R1, R2, R3, R4, X, Y are as defined in the description of invention, as multi-target directed ligands (MTDLs) that are at the same time inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR), their methods of preparation, formulations and therapeutic applications thereof.
AB - The invention provides compounds of Formula (I) or pharmaceutically acceptable salts thereof wherein Ar', R1, R2, R3, R4, X, Y are as defined in the description of invention, as multi-target directed ligands (MTDLs) that are at the same time inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR), their methods of preparation, formulations and therapeutic applications thereof.
M3 - Patent
M1 - WO2015/7615
ER -